Medications should not be drawn up in a patient treatment area according to the Joint Commission.

• A. True
• B. False
• C. Only for high-risk meds
• D. Not specified

Answer: (A)

Medications should be prepared in a designated medication preparation area, not in patient treatment areas. This standard helps prevent contamination, ensures proper aseptic technique, and reduces the chance of interruptions or distractions that can lead to errors. By keeping drug preparation separate from where patients are treated, the environment remains controlled, labels are accurate, and accountability is clearer.

So the statement is true: Joint Commission guidelines require drawing up medications in a proper preparation area rather than in the patient treatment space. Saying it’s not specified, or that it only applies to high-risk meds, would miss the general safety practice applied to all medications.